A Randomized, Double-Blinded, Placebo-Controlled Phase II Study Of Adjuvant Everolimus Following The Resection Of Metastatic Pancreatic Neuroendocrine
Posted Date: May 15, 2019
- Investigator: Shimul Shah
- Type of Study: Drug
The purpose of this study is to compare any good and bad effects of using the study drug, everolimus (also known as Afinitor), along with the usual monitoring after surgical removal of pancreatic neuroendocrine cancer tumor that has spread to the liver, to using the usual monitoring alone after surg
Criteria:
To Be Eligible, You Must Have Histologically Or Pathologically Confirmed Metastatic Low Or Intermedi
Keywords:
Liver, Cancer, Tumors, E2212, Pancreas
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu